208 related articles for article (PubMed ID: 20878273)
1. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
Hansson O; Zhou Y; Renström E; Osmark P
Curr Diab Rep; 2010 Dec; 10(6):444-51. PubMed ID: 20878273
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific alternative splicing of TCF7L2.
Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
[TBL] [Abstract][Full Text] [Related]
3. Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients.
Pradas-Juni M; Nicod N; Fernández-Rebollo E; Gomis R
Mol Endocrinol; 2014 Sep; 28(9):1558-70. PubMed ID: 25058603
[TBL] [Abstract][Full Text] [Related]
4. Unique splicing pattern of the TCF7L2 gene in human pancreatic islets.
Osmark P; Hansson O; Jonsson A; Rönn T; Groop L; Renström E
Diabetologia; 2009 May; 52(5):850-4. PubMed ID: 19247628
[TBL] [Abstract][Full Text] [Related]
5. Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans.
Mondal AK; Das SK; Baldini G; Chu WS; Sharma NK; Hackney OG; Zhao J; Grant SF; Elbein SC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1450-7. PubMed ID: 20097709
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes.
Pang DX; Smith AJ; Humphries SE
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):550-6. PubMed ID: 22402060
[TBL] [Abstract][Full Text] [Related]
7. TCF7L2 is a master regulator of insulin production and processing.
Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
[TBL] [Abstract][Full Text] [Related]
8. Rare intronic variants of TCF7L2 arising by selective sweeps in an indigenous population from Mexico.
Acosta JL; Hernández-Mondragón AC; Correa-Acosta LC; Cazañas-Padilla SN; Chávez-Florencio B; Ramírez-Vega EY; Monge-Cázares T; Aguilar-Salinas CA; Tusié-Luna T; Del Bosque-Plata L
BMC Genet; 2016 May; 17(1):68. PubMed ID: 27230431
[TBL] [Abstract][Full Text] [Related]
9. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.
Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA
Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050
[TBL] [Abstract][Full Text] [Related]
10. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
11. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
[TBL] [Abstract][Full Text] [Related]
12. TCF7L2 splice variants have distinct effects on beta-cell turnover and function.
Le Bacquer O; Shu L; Marchand M; Neve B; Paroni F; Kerr Conte J; Pattou F; Froguel P; Maedler K
Hum Mol Genet; 2011 May; 20(10):1906-15. PubMed ID: 21357677
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Del Bosque-Plata L; Martínez-Martínez E; Espinoza-Camacho MÁ; Gragnoli C
Diabetes; 2021 Jun; 70(6):1220-1228. PubMed ID: 34016596
[No Abstract] [Full Text] [Related]
14. Using gene-network landscape to dissect genotype effects of TCF7L2 genetic variant on diabetes and cardiovascular risk.
Vaquero AR; Ferreira NE; Omae SV; Rodrigues MV; Teixeira SK; Krieger JE; Pereira AC
Physiol Genomics; 2012 Oct; 44(19):903-14. PubMed ID: 22872755
[TBL] [Abstract][Full Text] [Related]
15. Developmentally regulated
Young RM; Ewan KB; Ferrer VP; Allende ML; Godovac-Zimmermann J; Dale TC; Wilson SW
Elife; 2019 Dec; 8():. PubMed ID: 31829936
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.
Prokunina-Olsson L; Kaplan LM; Schadt EE; Collins FS
PLoS One; 2009 Sep; 4(9):e7231. PubMed ID: 19789636
[TBL] [Abstract][Full Text] [Related]
17. TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
Verma M; Loh NY; Sabaratnam R; Vasan SK; van Dam AD; Todorčević M; Neville MJ; Toledo E; Karpe F; Christodoulides C
Metabolism; 2022 Aug; 133():155240. PubMed ID: 35697299
[TBL] [Abstract][Full Text] [Related]
18. The role of transcription factor 7-like 2 in metabolic disorders.
Zhang Z; Xu L; Xu X
Obes Rev; 2021 May; 22(5):e13166. PubMed ID: 33615650
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
20. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.
Nome T; Hoff AM; Bakken AC; Rognum TO; Nesbakken A; Skotheim RI
PLoS One; 2014; 9(3):e91264. PubMed ID: 24608966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]